These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33231251)

  • 1. REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers.
    Simitsi AM; Koros C; Stamelou M; Papadimitriou D; Leonardos A; Bougea A; Papagiannakis N; Pachi I; Angelopoulou E; Lourentzos K; Bonakis A; Stefanis L
    Sleep; 2021 May; 44(5):. PubMed ID: 33231251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Rapid Eye Movement Sleep Behavior Disorder on Obstructive Sleep Apnea Severity and Cognition of Parkinson's Disease Patients.
    Huang JY; Zhang JR; Shen Y; Zhang HJ; Cao YL; Mao CJ; Yang YP; Chen J; Liu CF; Li J
    Chin Med J (Engl); 2018 Apr; 131(8):899-906. PubMed ID: 29664048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal-Inoculation of α-Synuclein Preformed Fibrils Aggravated the Phenotypes of REM Sleep without Atonia in A53T BAC-SNCA Transgenic Mice.
    Okuda S; Nakayama T; Uemura N; Hikawa R; Ikuno M; Yamakado H; Inoue H; Tachibana N; Hayashi Y; Takahashi R; Egawa N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
    Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
    Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson's Disease Patients.
    Solla P; Wang Q; Frau C; Floris V; Loy F; Sechi LA; Masala C
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
    Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
    BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.
    Pont-Sunyer C; Iranzo A; Gaig C; Fernández-Arcos A; Vilas D; Valldeoriola F; Compta Y; Fernández-Santiago R; Fernández M; Bayés A; Calopa M; Casquero P; de Fàbregues O; Jaumà S; Puente V; Salamero M; José Martí M; Santamaría J; Tolosa E
    PLoS One; 2015; 10(7):e0132368. PubMed ID: 26177462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's disease.
    Cesari M; Christensen JAE; Muntean ML; Mollenhauer B; Sixel-Döring F; Sorensen HBD; Trenkwalder C; Jennum P
    Sleep Med; 2021 Jan; 77():238-248. PubMed ID: 32798136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sleep disordered breathing in REM sleep behavior disorder.
    Bugalho P; Mendonça M; Barbosa R; Salavisa M
    Sleep Med; 2017 Sep; 37():210-215. PubMed ID: 28673760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apathy in Parkinson's disease with REM sleep behavior disorder.
    Bargiotas P; Ntafouli M; Lachenmayer ML; Krack P; Schüpbach WMM; Bassetti CLA
    J Neurol Sci; 2019 Apr; 399():194-198. PubMed ID: 30826716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study.
    Piano C; Losurdo A; Della Marca G; Solito M; Calandra-Buonaura G; Provini F; Bentivoglio AR; Cortelli P
    Sleep; 2015 Sep; 38(9):1489-95. PubMed ID: 25845698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder.
    Aguirre-Mardones C; Iranzo A; Vilas D; Serradell M; Gaig C; Santamaría J; Tolosa E
    J Neurol; 2015 Jun; 262(6):1568-78. PubMed ID: 25929658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic Limb Movements During Sleep Mimicking REM Sleep Behavior Disorder: A New Form of Periodic Limb Movement Disorder.
    Gaig C; Iranzo A; Pujol M; Perez H; Santamaria J
    Sleep; 2017 Mar; 40(3):. PubMed ID: 28364416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease.
    Halsband C; Zapf A; Sixel-Döring F; Trenkwalder C; Mollenhauer B
    Mov Disord Clin Pract; 2018; 5(2):171-176. PubMed ID: 30009211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.